Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 Tumors

(2012) Romana Mikyšková et al.   JOURNAL OF IMMUNOTHERAPY

Long-term remission of an advanced recurrent endometrial cancer in a heavily pretreated patient using a combined regimen with bevacizumab and metronomic cyclophosphamide

(2011) Judith Reinhardt et al.   ANTI-CANCER DRUGS

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

(2011) O A Khan et al.   BRITISH JOURNAL OF CANCER

Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma

(2011) Olivier Mir et al.   EUROPEAN JOURNAL OF CANCER

Low-Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma

(2011) J.H. Burton et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer

(2010) Alfonso Sánchez-Muñoz et al.   ONCOLOGY

Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model

(2009) S. Wada et al.   CANCER RESEARCH

Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications

(2009) C. H. Chung et al.   CLINICAL CANCER RESEARCH

Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation

(2009) Leisha A. Emens et al.   JOURNAL OF CLINICAL ONCOLOGY

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer treatment: the combination of vaccination with other therapies

(2008) Mads Hald Andersen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

(2008) C. L. Trimble et al.   CLINICAL CANCER RESEARCH

Effective Depletion of Regulatory T Cells Allows the Recruitment of Mesothelin-Specific CD8+T Cells to the Antitumor Immune Response Against a Mesothelin-Expressing Mouse Pancreatic Adenocarcinoma

(2008) Ihid C. Leao et al.   CTS-Clinical and Translational Science

Immunotherapy for head and neck cancer

(2008) Annie A. Wu et al.   JOURNAL OF BIOMEDICAL SCIENCE

Regulatory T Cells: Mechanisms of Differentiation and Function

(2007) Steven Z. Josefowicz et al.   Annual Review of Immunology